@article{a0f5a742dd2249459771658bc64daa98,
title = "Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers",
keywords = "BRCA1, BRCA2, Breast cancer, Oophorectomy, Tamoxifen",
author = "Daniel Rayson",
note = "Funding Information: Acknowledgements We would like to thank study coordinators Adriana Valentini, Marcia Llacuachaqui, and Alejandra Ragone, as well as Jennifer Ng, Kristi De Buono, Kate Bisnaire, Dina Nikitina, Anneli Loo, Bita Khorram, Dina Gordon, Courtney May, Michelle Jones, Jose Miguel Lozano and Linda Steele who helped with the data collection and data entry. Supported by grants from the Canadian Breast Cancer Research Alliance and the Canadian Cancer Society Research Initiative and an ICARE grant IBG09-34198 awarded to T. Pal. SLN is the Morris and Horowitz Families Endowed Professor, and the work was supported by NIH R01 CA74415.",
year = "2014",
month = jul,
doi = "10.1007/s10549-014-3026-3",
language = "English",
volume = "146",
pages = "421--427",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",
}
